Doxazosin Tablet
Product Images NDC 71335-0349

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-0349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Doxazosin Fig1)

Table showing the summary of effectiveness data in placebo-controlled trials for Doxazosin, including symptom score and maximum flow rate changes compared to placebo. It includes data from three studies with titration to various doses and a bar graph illustrating maximum flow rate and symptom score changes for placebo, 4 mg, and 8 mg dosages.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

This image shows two line graphs depicting the effects of Doxazosin treatment compared to placebo over 14 weeks. The left graph illustrates the mean change in total symptom score from baseline, with Doxazosin showing a greater reduction than placebo. The right graph depicts the mean increase in maximum urinary flow rate from baseline, with Doxazosin demonstrating a larger increase than placebo. Both graphs include error bars and indicate statistical significance at various points.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure diagram of doxazosin mesylate, an active ingredient in the product Doxazosin 4 mg by Bryant Ranch Prepack. The structure includes aromatic rings, nitrogen-containing heterocycles, and methoxy groups, consistent with doxazosin mesylate's chemical representation.*

FDA Label Image

Label (Lbl713350349)

Label for Doxazosin Mesylate 4 mg tablets packaged by Bryant Ranch Prepack. The label indicates the product is a yellow, round tablet identified with imprint C4, and is a generic comparable to Cardura 4 mg tablets by Intas Pharmaceuticals Limited. The package contains 100 tablets with storage instructions to keep at room temperature 20°-25°C (68°-77°F). The NDC number 71335-0349-1 is highlighted along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.